Abstract This review summarizes recent advances and future research trends in the field of phospholipid-based biomaterials. Lipids play an important role in biomineralization and countless other biological processes, and they are receiving increasing attention for the synthesis of new biomimetic biomaterials. Several emerging strategies in biomaterials research take advantage of phospholipids to compartmentalize and/or template chemical reactions via self-assembled structures such as liposomes and tubules. Still others exploit the inherent biocompatibility of phospholipids and phospholipid-mimetic materials for use as novel tissue-contacting biomaterials that mimic biological membranes. In the future, phospholipid-based materials may be increasingly utilized as tools for the manipulation of cell and tissue responses to biomaterials, for controlled drug release, for reconstructive surgery, and as tissue-engineered constructs.
INTRODUCTION
Lipids comprise a diverse and essential class of biomolecules. Their involvement in biological processes is ubiquitous and includes the construction of biomembranes, the transduction of cellular signals, their use as a source of energy, and countless other biochemical pathways. One biological process in which lipids play an important role is the synthesis of materials. Through their ability to self-assemble, compartmentalize, and template, lipids enable the formation of a large variety of materials with controlled micro-and nanostructures. Acknowledging this involvement of lipids in natural materials synthesis, a new field is emerging that seeks to use the natural roles of lipids as inspiration for the development of new routes for materials synthesis. This review focuses on the link between how lipid structures are utilized in nature and how these ideas from nature are being exploited to synthesize novel synthetic biomaterials. This review is not intended to be an exhaustive listing of work being done using lipid-based biomaterials strategies, as several important biomedical applications of lipids, including their use in systemic drug delivery and gene therapy, are not discussed in detail. We begin with a brief overview of lipid structure and self-assembly, along with a discussion of the roles that lipids play in the synthesis of natural biological materials. This is followed by a review of the recent literature on bio-inspired phospholipid-based strategies for developing novel mineralized materials. The latter half of the review focuses on more applied aspects of phospholipid biomaterials, including (a) approaches using phospholipid vesicles for the delivery of reactive species, therapeutic agents, or macromolecules, (b) tubule, ribbon, and network assemblies of phospholipids for drug delivery and as tissue-engineering scaffolds, and (c) membrane-mimetic materials for the enhancement of tissue-material interfaces.
STRUCTURE AND ASSEMBLY OF LIPIDS
The ultimate utility of lipids lies in their ability to self-organize into specific supramolecular aggregates-an attribute conferred by the inherent amphiphilic nature of this diverse class of biomolecules. Because a complete cataloguing of lipid structures is beyond the scope of this review, we instead qualitatively describe the fundamental chemical features of lipids, the major aggregate structures that lipids commonly form, and factors that control phase behavior. Several excellent sources are available for more detailed structural and phase information (1) (2) (3) .
Chemical Structure
Most lipids are composed of three essential features: a polar head group, one or more hydrophobic tail regions, and a backbone structure that connects the two ( Figure 1 ). These three building blocks are assembled in an extraordinary variety of ways to generate all of the naturally occurring amphiphilic lipids. Tail regions can contain aromatic groups, saturated aliphatic chains, or unsaturated aliphatic chains, and head groups can consist of any number of charged or uncharged polar moieties. Backbone structures occur in similar diversity, from polyol-based structures such as glycerol, to the aromatic polycyclic structures of cholesterol and other isoprenoids. Owing to the large variability in head group and tail chemistries, lipids are often categorized according to backbone structure: isoprenoids, phospholipids, sphingolipids, ceramides, fatty acids, triacylglycerols, eicosanoids, waxes, and glycerophospholipids. Within each of these categories, numerous variants exist that are the result of head group or tail modifications. For example, glycerophospholipids, the primary constituents of biomembranes, are composed of two fatty acid chains esterified at C-1 and C-2 of glycerol-3-phosphate ( Figure 1 ). The acyl chains are typically 8 to 24 carbons long, and they can be saturated, unsaturated, or even coupled to form a macrocycle. Typically, an ester linkage couples the glycerophosphate to one of several head group compounds such as choline, ethanolamine, or serine to form phosphatidylcholine, phosphatidylethanolamine, or phosphatidylserine, respectively. Such head group modifications may render the lipids either charged, uncharged, or zwitterionic at physiologic pH.
Simple Supramolecular Aggregates of Lipids: Monolayers, Micelles, Bilayers, and Liposomes
When dispersed in a solvent such as water, lipids exhibit a strong tendency to selfassemble into a variety of mesophase structures, including monolayers, micelles, reverse micelles, bilayers, and hexagonal phases ( Figure 2 ). The aqueous phase behavior of lipids is dictated by intrinsic parameters such as lipid polarity, acyl chain length, location and extent of acyl chain unsaturation, acyl chain branching, head group size, head group polarity, and head group charge, as well as extrinsic parameters such as concentration (lyotropism) and temperature (thermotropism) (2) (3) (4) (5) . For example, increasing acyl chain length results in higher bilayer melting temperatures, whereas the introduction of unsaturated bonds has the opposite effect owing to the disruption of molecular packing and ordering among the fatty chains. Furthermore, in addition to lowering the bilayer melting temperature, the presence of unsaturated bonds can also induce the formation of nonlamellar phases. Head group properties (especially polarity) also impact the phase behavior of lipids by modulating the strength of interaction between head groups and between the head groups and water.
Monolayers are among the simplest structures of lipids. They are nevertheless exceptionally useful as controlled experimental models for the investigation of lipid interactions, lipid surface chemistry, and membrane dynamics. Assembled most commonly at the interface between aqueous media and air, monolayers are formed when an organic lipid solution is spread onto water. Upon evaporation of the organic solvent, the hydrophilic region of the molecule embeds in the aqueous phase to maximize polar interactions, and the hydrocarbon region protrudes into the gaseous phase to maximize hydrophobic interactions. Micelles (Figure 2a ) are spherical aggregates commonly formed by single-tailed lipids such as bile acids and other surfactants. Formed from 10 to over 100 single molecules in water, micelles minimize their hydrophobic interactions by clustering their hydrocarbon tails in their interiors and exposing their polar head groups to the surrounding aqueous medium. In apolar solvents, inverse micelles are formed, with the hydrophilic head groups clustering in the center (Figure 2b ). Many lipids, including phospholipids with acyl chains longer than about eight carbons, do not form micelles because their hydrophobic regions are too bulky to fit inside the micellar structure (4). Instead, these lipids form a common and biologically important mesophase, the lamellar bilayer (Figure 2c ).
Lipid bilayers are the major building blocks of biological membranes that, together with membrane proteins and cholesterol, control cell shape and many cell functions such as the storage of compounds, ion transport, cell fusion, and metabolism. Bilayers exhibit a surprising variety in their phase behavior, forming various shapes and textures such as ripples or saddles (6) . Because a planar bilayer sheet dispersed in water would be in the energetically unfavorable position of having its hydrophobic regions exposed to water at its edges, self-organization of phospholipid bilayers usually occurs by the formation of closed vesicles, often referred to as liposomes (Figure 2d ). Liposomes can be formed in the laboratory using several approaches, perhaps most easily by spontaneous formation when a thin film of lipid is heated above a critical temperature in water. Liposomes range in size from tens of nanometers to tens of microns in diameter and can be made to entrap hydrophilic materials in their inner compartment and/or hydrophobic materials in their membranes. Because of their ability to entrap and compartmentalize, liposomes have received widespread attention as drug-delivery vehicles that can be injected into the blood stream to deliver encapsulated drugs to specific organs, tissues, or cells (7).
MINERALIZATION IN LIPID ASSEMBLIES: A Common Biological Strategy
Biological mineral synthesis, in contrast to conventional mineral-processing techniques, generates materials of very highly controlled size, habit, texture, composition, and structure. Studies of biomineralization processes during the past several decades have yielded extensive information on how nature achieves such exquisite control over mineral formation. These biomineralization processes occur in a diversity of species and tissues, including bone mineral, marine shells, tooth enamel, and marine algae shells. Several excellent reviews of biomineralization have been published (8) (9) (10) (11) . In many types of biomineralization, macromolecular structures composed of lipids, proteins, and/or polysaccharides are intimately associated with mineral phases and serve vital roles in their crystallization. For example, one ubiquitous biological strategy employed during the formation of mineral phases exploits lipid assemblies to control the location, size, composition, and shape of mineral crystals. Phospholipids, often in the form of bilayer vesicles, are commonly employed in natural biomineralization processes to delineate reaction compartments into which mineral formation takes place (8) . Although phospholipid mesophase-mediated mineralization occurs in vastly different species and tissues, the roles that the phospholipid assemblies play in these processes can be generalized as follows:
1. construction of a compartmentalized reaction environment, often through the use of bilayer vesicles; 2. control of the physicochemical conditions inside the reaction environment via transmembrane channels, transporters, or selective ion permeability;
3. control of nucleation kinetics. The organic surface serves as a molecular blueprint for the site-directed formation of the inorganic phase by providing an interface in which the electrostatic, stereochemical, and geometric interactions are conducive to oriented nucleation and growth of the mineral (11); 4. control of the shape and size of the crystal by the reaction compartment.
Production of complex crystal shapes is attained by altering the shape of the lipid matrix during crystal growth.
Coccoliths, Matrix Vesicles, and Magnetosomes
To further highlight the ways in which phospholipids play a key role in biomineralization processes, we offer three examples of biominerals that form within the compartments of lipid assemblies: the coccolith of the marine alga Emiliania huxleyi, matrix vesicles found in the mineralizing tissues of vertebrates, and magnetosomes found in magnetotactic bacteria. These examples are from vastly different organisms, yet in each case the formation of the inorganic phases follows several general strategies that can be adapted to the laboratory. The first example is the formation of coccoliths in the alga Emiliania huxleyi (12) . Coccoliths are scales that consist of 30-40 calcite (CaCO 3 ) crystals arranged within an ovalshaped structure, and several coccoliths are used by the alga as an exoskeleton to surround and protect itself. The first stage of organized assembly of these structures is the production of a series of phospholipid membrane vesicles that act as compartments for the subsequent calcite crystallization. Other encapsulation structures such as proteins or polysaccharide networks are also utilized in biomineralization processes. The second stage of crystallization includes the influx of calcium and carbonate ions. Then, in the third stage, oriented nucleation of calcite crystals occurs within the enclosed vesicles. This is aided by structural, chiral, and chemical complementarity between the organic matrix and the nucleating mineral phase. In the final stage of mineralization, the desired shape of the mineral crystal is achieved by control of the vesicle compartment shape via active cellular cytoskeletal elements. Such dynamic control of crystal shape by the phospholipid mesophase leads to the highly elaborate structures found in coccoliths.
Vertebrates also initiate mineral formation within lipid vesicles and lipopeptide aggregates. Noncellular phospholipid vesicles (matrix vesicles) are found in certain actively mineralizing tissues of the human body, including growth plate cartilage and growing dentin, and are the initial sites of calcification in these tissues (13) . Matrix vesicles are unilamellar bilayer vesicles, 100-200 nm in diameter, that are formed by budding from hypertrophic chondrocytes and odontoblasts. The membranes of these vesicles are enriched in acidic (i.e., negatively charged at physiologic pH) phospholipids, ion channels, enzymes, and transport proteins. At the time of release from the cell membrane, matrix vesicles do not contain mineralized crystals. However, as the vesicle becomes embedded within the extracellular matrix secreted by the cell, the interior of the vesicle becomes enriched with Ca 2+ and PO 4 − , in part by the action of calcium-binding phospholipids and proteins, phospholipase enzymes, and calcium ion channels. When the concentrations of Ca 2+ and PO 4 − reach supersaturation levels in the vesicle compartment, calcium phosphate mineral then precipitates on the interior surface of the vesicle in the form of amorphous calcium phosphate or poorly crystalline apatite (13) . Nucleation at the inner surface of the vesicle membrane appears to be assisted by the chemical and structural complementarity of the inner phospholipid-protein assembly of the matrix vesicle and the mineral phase. Upon further growth, the hydroxyapatite crystals then penetrate the vesicle membrane. Once the membrane has been perforated by the crystal, further mineralization is governed by solution conditions of the extracellular fluid. By this mechanism, matrix vesicles effectively control the initial nucleation kinetics and crystal structure of the biomineral.
Eanes and coworkers utilized lipid vesicles in their work on in vitro models of matrix vesicle mineralization (14) (15) (16) (17) (18) (19) . In synthetic vesicles of similar lipid composition to matrix vesicles, calcium phosphate crystals nucleated and grew, then ruptured the membranes and seeded further precipitation from the surrounding solution (15) . Furthermore, the formation of calcium phosphate could be modulated by altering the permeability of the membrane with cholesterol (17, 18) . Much of our current understanding of matrix vesicle mineralization is a result of this work, which employed simulated physiologic conditions to model the sequence of events that occurs during matrix vesicle mineralization.
Another interesting example of phospholipid and organic matrix-mediated mineralization is magnetosomes, which are biologically derived single crystals of magnetite (Fe 3 O 4 ) or greigite (Fe 3 S 4 ) encapsulated in a bilayer vesicle. Magnetosomes are found in certain species of bacteria, and their mechanism of formation shares several common features with matrix vesicle and coccolith formation (20) (21) (22) . Magnetosomes are highly crystalline, and their sizes and crystal habits are particularly uniform within individual bacterial species. Long chains of interconnected magnetosomes with a common magnetic orientation are often seen in the cytoplasm of magnetotactic bacteria. These organisms are believed to have evolved to utilize these structures, which possess a permanent magnetic dipole, to navigate with respect to the earth's magnetic field. As with coccoliths and matrix vesicles, magnetosomes are formed by the precipitation of mineral within preformed lipid vesicles, which exert a high level of control over crystallization by virtue of the compartmentalization and templating effect of the membrane surrounding the particle. Molecular recognition at the inner vesicle surface is likely to play a role in control of magnetite crystal orientation.
Lipid Strategies in Materials Research
As coccolith, matrix vesicle, and magnetosome mineralization demonstrate, lipid assemblies should not be viewed merely as passive hosts to enclose mineralization reactions, for compartmentalization is only the most basic role that lipids play in the biomineralization process. The formation of a lipid vesicle compartment results in the presentation of an organic matrix to the nucleation environment, the surface of which can strongly influence the growing inorganic phase through the molecular recognition processes of chemical, electrostatic, and chiral complementarity. Lipid monolayers are particularly useful experimental systems for studying these interactions because they are simple and modifiable. Using monolayers, Mann et al and Heywood & Mann have investigated several essential features of the organic-inorganic interface in biomimetic mineralization. For example, they used compressed Langmuir monolayers to control the crystal orientation of nucleating calcium carbonate (23, 24) . Initially they used compressed stearic acid monolayers to control the crystallization of CaCO 3 from supersaturated solutions, finding that the presence of an organized monolayer gave rise to oriented vaterite phases that formed specifically at the monolayer interface, where the absence of the monolayer resulted in non-uniform rhombohedral calcite crystals that precipitated in multiple locations. Furthermore, the degree of compression of the monolayer dictated the homogeneity of vaterite nucleation (25) . In essence, stereochemical and electrostatic matching were the primary contributors to the observed phase changes. To further explore this idea, they then observed crystallization under monolayers of different stereochemistry. Whereas n-octadecanoic acid (which forms bidentate motifs) induced the nucleation of the {110} face of calcite, n-eicosyl phosphonate and n-eicosyl sulfate (which form tridentate motifs) induced the nucleation of the (001) face. Aragonite also showed similar dependence on head group choice. This supports the idea that an interfacial mechanism exists involving stereochemical complementarity between the oxygen atoms of the anionic head group and those of carbonate ions located in lattice positions in the crystal faces of nuclei forming at the organic/inorganic interface. Depending on the stereochemical and electrostatic properties of the phospholipid lattice presented to the nucleating crystal, different faces could be nucleated.
Several laboratories have sought to mimic compartmental biomineralization to synthetically generate inorganic phases with the controlled features of biominerals. In general, these in vitro experiments have attempted to exploit the aqueous inner compartment of liposomes as micro-or nanoscale reaction volumes to form inorganic particles of controlled size and shape. An early approach by Mann and coworkers involved the precipitation of silver oxide inside phosphatidylcholine vesicles (26) . In that work, liposomes containing entrapped aqueous silver nitrate were dispersed in a Ag-free alkaline aqueous medium. Under the conditions of the experiment, the Ag 2+ ions had low permeability across the lipid bilayer membrane and therefore remained entrapped within the vesicles. However, OH − ions with much higher permeability gradually diffused into the vesicle compartment, resulting in an intravesicular pH increase and precipitation of Ag 2 O. The crystals that resulted, which formed only inside the liposomes, were essentially of homogeneous size, unlike precipitates formed directly from an analogous lipidfree solution strategy. Similar approaches have been successfully used to generate iron oxide microparticles (27) , aluminum oxide particles (29) , and nanocomposite particles of aluminum, magnesium, and calcium hydroxides (28, 30) . Also, the generation of nanoparticles is of particular interest in semiconductor engineering, and Fendler and coworkers have extensively utilized compartmental synthesis techniques in creating semiconductor particles with unique properties (31) (32) (33) . The potential applications of such highly controlled inorganic particles include catalysis, recording media, antibody-tagged magnetic particles for molecular biology, and contrast agents for medical imaging.
In addition to vesicles, some bilayer-forming lipids adopt extended nonspherical assemblies such as tubules, filaments, and networks that can be used as templates for materials synthesis. For example, mixtures of galactocerebrosides such as α-hydroxy fatty acid galactocerebroside and non-hydroxy fatty acid galactocerebroside self-assemble into lamellar disks, multilamellar tubules, or fibrous unilamellar tubules in ethylene glycol (34) . The inclusion of low levels of anionic, sulfated galactocerebroside into the neutral lipid microstructures gives the microtubules anionic sites for electrostatic binding of cations, and inorganic oxide nucleation can occur on the microtubule surface (35) . Microtubules constructed from diacetylene-containing phospholipids have been used as templates to generate solid silica microtubules (36) , and nanoparticles of silica (37) and gold (38) have also been selectively arranged on the lipid tubule template to generate patterned three-dimensional objects. Studies have also shown that mineral phases are not the only materials that can be synthesized on these tubule surfaces, as lipid tubules have been utilized for the templating of polymers (39) , proteins (40) , and metals (41) .
PHOSPHOLIPID STRATEGIES IN BIOMATERIALS RESEARCH
We now shift our attention from describing the role of phospholipids in biomineralization to specific applications of phospholipid assemblies as biomaterials. For the purposes of this discussion, we define a biomaterial as any material of natural or synthetic origin that is used for the repair, replacement, reconstruction, or treatment of diseased or traumatized tissue. Although the use of phospholipids as vectors for gene therapy and liposome-based systemic drug-delivery systems certainly falls within this definition, these topics have been reviewed elsewhere and are not the focus of this section. Instead, we focus on phospholipid-based biomaterials strategies that vary widely in approach but can be grouped into three major categories: (a) those that utilize lipid vesicles for the delivery of reactive species, therapeutic agents, or macromolecules; (b) tubule, ribbon, and network assemblies of phospholipids for drug delivery and as scaffolds for tissue-engineering applications; and (c) monolayer, bilayer, or membrane-mimetic materials for the enhancement of tissue-material interfaces. The first two of these categories make use of the unique properties of phospholipids to encapsulate and/or template via selfassembled structures such as liposomes and tubules, whereas the latter takes advantage of the inherent biocompatibility of lipids as surface coatings and membranemimetic systems that offer new approaches for engineering novel tissue-contacting biomaterials that mimic biological membranes.
Liposomes and Liposome-Containing Hydrogels
The use of liposomes to encapsulate materials has received widespread attention for the systemic (i.e., intravenous) delivery of drugs and diagnostic reagents (7). Historically, the major barrier to using liposomes for systemic drug delivery has been the rapid clearance of liposomes from the bloodstream by the reticuloendothelial system. Although there is renewed interest in systemic liposome delivery because of recent progress in the use of steric stabilization for increasing the blood circulation lifetimes of liposomes, it is important to note that significant challenges still exist for systemic delivery of liposomes and for the targeting of liposomes to specific tissues or organs. Moreover, some treatments may benefit from a localized approach to sustained delivery of drugs rather than systemic delivery. For example, a drug-releasing gel material that could be injected into a solid tumor to deliver chemotherapeutic agents for extended time periods has been widely envisaged.
Several attempts have been made to combine the beneficial properties of liposomes and polymer matrices to develop materials that can sequester and retain liposomes at a discrete tissue site. In most cases, the role of the polymer is to provide a bulk matrix within which the liposomes are entrapped, whereas the function of the liposomes is to provide a reservoir from which drug is released in a controlled manner. Liposome-hydrogel composites have been designed with several applications in mind, including conformal drug-releasing coatings to prevent bacterial adhesions to catheters (42) , the prolonged delivery of antigens for enhanced immunization procedures (43, 44) , and the delivery of hormones (45) . Additional applications of liposome-hydrogel constructs include topical dressings for transcutaneous drug delivery (46) and for the prolonged delivery of substances to cell cultures.
Several different types of matrix materials have been investigated for this purpose, including biopolymeric materials such as collagen (45) , chitosan (47), alginate (48-50), alginate-poly(lysine) (43) , and gelatin (51) . Although sequestration of liposomes in these gels and the evaluation of the liposomes' release profiles is easily achieved, some difficulties have been encountered in the development of these hydrogel-liposome composites. The most significant of these is the tendency of matrix polymers to interact with the liposomal membrane. An example of this is the interaction of alginate with phospholipid bilayers, which results in alteration of the barrier properties of liposomes (52, 53) . To prevent such interactions from adversely affecting the release properties of liposomes, more sophisticated strategies involving the introduction of specific functional groups at the liposome surface or within the hydrogel are being investigated. For example, to minimize liposome/matrix polymer interactions, PEGylated lipids have recently been utilized to form a steric barrier around gelatin-embedded liposomes (51) . The presence of the PEG chains at the liposome surface prevents membrane disruption by forming a polymeric barrier that sterically inhibits interaction between soluble or matrix polymer and the lipid bilayer.
Triggerable Liposomes and Their Use for In Situ Formation of Biomaterials
In recent years, considerable work has been directed at constructing lipid vesicles that can be induced to release entrapped materials in response to an applied stimulus (54) . Typically, the goal has been to trigger site-directed delivery of therapeutic agents. Early work in this area by Yatvin and coworkers utilized temperaturesensitive liposomes in combination with local hyperthermia to deliver a chemotherapeutic agent to a tumor site (55, 56) . More recently, photo-, pH-, and other stimulus-responsive systems have been investigated (54, (57) (58) (59) (60) (61) (62) (63) .
By virtue of their ability to entrap and release reagents under controlled conditions, it is also possible to exploit stimuli-responsive liposomes as a means of controlling chemical reactions that result in the rapid formation of a biomaterial. An ongoing effort in our laboratory is concerned with using stimuli-responsive liposomes for rapid in situ formation of mineral, polymer, and mineral/polymer composite biomaterials, with the goal of developing a versatile approach to inducing rapid in situ formation of biomaterials in response to an applied stimulus (53, (64) (65) (66) (67) .
Our general strategy ( Figure 3 ) has been to exploit the controllable barrier properties of the bilayer membrane of phospholipid liposomes to encapsulate ions and physically isolate them from reactive species contained within the free (extravesicular) aqueous medium. By using stimuli-responsive lipid vesicles, one is able to create systems in which chemical reactions between the encapsulated species and the extravesicular species are made possible only in response to specific stimuli, such as a change in temperature or pH, or by exposure to light of a specific wavelength. As a result of either a specific physical or chemical (i.e., degradative) mechanism, the applied stimulus induces a change in bilayer barrier properties, resulting in release of the entrapped species. Upon release from the liposome compartment, the entrapped reagent either catalyzes or participates directly in a chemical reaction that results in the formation of a biomaterial.
Much of our work in this area has involved the use of temperature changes to activate liposome-mediated biomaterial formation. This approach exploits the release of entrapped substances from liposomes at temperatures near the lipid chain melting transition (T m ), a temperature at which bilayer permeability is known to Figure 3 Schematic illustration of general strategy for utilizing stimuli-responsive lipid vesicles for in situ formation of biomaterials. A, B, and C represent reactive solutes, such as organic/inorganic ionic species, low-molecular weight organic molecules, or polymers. Exposure of the liposome suspension to an applied stimulus triggers release of entrapped reagent (A), which reacts with components of the free medium (B and/or C) to form a solid or semi-solid biomaterial. Alternatively, release of entrapped reagent may be used to catalyze reaction between non-entrapped species.
be significantly enhanced (68) . As illustrated in Figure 4 , at temperatures below T m , phosphatidylcholine bilayers are in the gel phase (L β ), which has low permeability to encapsulated monovalent and divalent cations. Above T m , the bilayers are fluid (L α phase) but still have relatively low permeability. However at T m , lipid bilayer permeability has been observed to increase by several orders of magnitude, a phenomenon attributed to the presence of highly permeable interfacial regions between coexisting gel (<T m ) and fluid (>T m ) bilayer domains (69, 70) . This fundamental characteristic of phospholipid bilayers permits the design of reagentfilled liposomes that are relatively impermeable to encapsulated molecules at one temperature but highly permeable at another temperature. If the initial concentration of an ion or low-molecular weight molecule is high inside the liposome but low outside, heating to T m will result in diffusion of the entrapped species down a large concentration gradient, effectively releasing the entrapped species into the extravesicular medium.
Our initial goal was to employ liposomes composed of lipids having T m between ambient and body temperature (37 • C), so that the thermal release mechanism described above could be used to trigger biomaterial formation when a fluid precursor suspension was injected into a warm tissue or body cavity. For this purpose we chose saturated phosphatidylcholines, in which T m is determined primarily by the fatty acid chain length ( Figure 5 ). By selecting phospholipids with appropriate fatty acid chain lengths and ones that exhibit miscibility, such as dimyristoyl phosphatidylcholine (DMPC) and dipalmitoyl phosphatidylcholine (DPPC), we have been able to tailor the T m of the bilayer in the range of 23 to 41
• C. For example, a 9:1 molar ratio of DPPC to DMPC resulted in a T m that coincides with the body's temperature of 37
• C; liposomes of this composition that contain CaCl 2 released approximately 90% of entrapped Ca 2+ between 36 and 38
• C (Figure 6 ). By adjusting the DPPC/DMPC molar ratio, we were capable of tailoring the T m to less than 37
• C (65); such flexibility could be useful in adjusting these systems to lower temperatures, such as might be encountered in a limb or on the external surface of the body.
Initially, we applied this strategy to the formation of calcium phosphate minerals by designing thermally responsive liposomes in which mineral formation was activated when the liposome suspension was heated from ambient to physiologic temperature (65) . Separately, calcium-and phosphate-loaded liposomes were prepared and mixed together to form a suspension of equal calcium and inorganic phosphate concentration, and highly supersaturated with respect to calcium phosphate solids such as hydroxyapatite. The suspension could be stored for several weeks at room temperature without detectable mineral formation, reflecting the low bilayer permeability of ions in the gel state. However, when the liposome suspension was heated to the T m of the lipid mixture, calcium and phosphate ions were released into the extravesicular fluid, where, owing to their high concentrations, they rapidly reacted to form calcium phosphate mineral. The mineral phases formed by this strategy included apatite and brushite and could be systematically controlled through manipulation of the pH of the reaction medium (65) . In subsequent in vitro experiments we demonstrated how this approach can be used to form calcium phosphate minerals on human enamel and dentin surfaces by exploiting the increased temperature of the oral cavity ( Figure 7 ) (67). The results of these studies suggest that this approach to mineral formation could be used to remineralize tooth surfaces or even possibly for in situ formation of bone repair materials.
We have also used this liposome strategy to elicit rapid in situ formation of polymer hydrogel biomaterials. Having previously developed triggerable Ca 2+ -loaded vesicles for our mineralization studies, we hypothesized that we could employ the triggered release of calcium to induce hydrogel formation. By utilizing calciumreactive macromolecules such as alginates and calcium-dependent enzymes that cross-link proteins, we have developed liposomal suspensions that are stable and fluid at room temperature but rapidly form polymer hydrogels at physiologic temperature (53, 64, 66) . In the alginate system, a precursor fluid consisting of Ca 2+ -loaded liposomes dispersed in a low viscosity Na-alginate solution remains fluid for several days at ambient temperature. Heating of the precursor fluid to T m triggers Ca 2+ release from the liposomes; the calcium in turn cross-links Naalginate to form a Ca-alginate hydrogel. Characterization of the gelation kinetics reveals that gelation is very rapid in this system (on the order of tens of seconds as shown in Figure 8 ) when the temperature of the precursor fluid reaches T m . A consequence of the formation of the Ca-alginate hydrogel is the entrapment of liposomes within the gel matrix; these liposomes can be employed as drug reservoirs for controlled release from in situ formed hydrogels (66) .
To create protein-based hydrogels, one can take advantage of biological enzymes to catalyze enzyme-mediated cross-linking of macromolecular substrates. Transglutaminases (TGases) are enzymes that catalyze the formation of crosslinks between glutamine-and lysine-containing proteins and have been used to form proteinaceous hydrogels (71, 72) . TGase enzymes require Ca 2+ for activity and therefore can be triggered from an inactive to an active state by release of Ca 2+ from liposomes. We used thermally triggerable Ca 2+ -loaded liposomes and TGase
Figure 8
Thermally triggered gelation of alginate using calcium-loaded liposomes. Ca 2+ -loaded liposomes dispersed in aqueous NaCl were mixed with a Na-alginate solution and loaded into a glass capillary at room temperature. The capillary was then immersed in a 37 • C water bath for 20 s, after which the contents of the capillary were partially expelled to reveal the formation of Ca-alginate hydrogel. Reprinted from (53) with permission from Elsevier Science.
in combination with a macromolecular TGase substrate (fibrinogen) to develop in situ gelling proteinaceous hydrogels (53) . Figure 9 shows the rheological properties of these alginate and fibrinogen gels as they solidify. Only suspensions that contained Ca 2+ -loaded liposomes and were heated to 37
• C allowed Ca 2+ release and subsequent gel evolution.
In contrast to the liposome-encapsulated hydrogel systems described above, in which the liposomes act as simple reservoirs for passive release of therapeutic agents, in our approach to rapid in situ formation of biomaterials the liposomes actively participate in the reactions that result in formation of a bulk material. This strategy was designed to take advantage of the clinical versatility of fluid liposome suspensions that are stable during storage at or below room temperature but that rapidly form a hydrogel upon injection into the body. The method of administration (i.e., injection via syringe) of these biomaterials is expected to be much less invasive compared with conventional surgical administration of biomaterials. In the future, this versatile strategy could be utilized for the delivery of biomaterials for tissue repair, reconstructive surgery, and local site-directed drug delivery.
Tubule, Ribbon, and Network Assemblies
In addition to spherical lipid assemblies, lipid tubules have also been explored for encapsulating and releasing bioactive molecules with unique kinetics. Like liposomes, lipid tubules can be loaded with drugs or other bioactive substances for controlled release purposes. In contrast to liposomes, however, drug release from tubules is expected to exhibit zero-order release kinetics under certain conditions. A widely studied tubule-forming lipid is the polymerizable diacetylene-containing , and fibrinogen were combined in buffer and monitored by oscillating rheometry. The rheometer was equilibrated at either 20 • or 37 • C prior to loading the precursor fluid and beginning data collection. Ca 2+ -free liposomes (Na-IFVs) were used as a control to illustrate the Ca 2+ dependence of enzyme cross-linking. The rise in storage modulus seen in the samples heated to 37 • C is a result of Ca 2+ release from the liposomes, which activates enzymatic cross-linking of soluble fibrinogen by hrFXIII. Reprinted from (53) with permission from Elsevier Science. phospholipid 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine (DC 8,9 PC) which, under certain conditions, can spontaneously form hollow microtubules ( Figure 10 ) consisting of one or more bilayers (73) . Depending on specific processing parameters such as temperature, concentration, and solvent mixture, the dimensions (74-76) and thermodynamic properties (77) of these tubules can be controlled and modified. Zero-order release kinetics were observed over the course of 10 days using DC 8, 9 PC tubules containing radiolabeled growth factors (78) . Furthermore, when subjected to hydrolysis by phospholipase enzymes, DC 8, 9 PC tubules degraded in a zero-order fashion as well (79) . Zero-order release profiles are highly desired for releasing constant amounts of therapeutic agents for extended periods of time.
C 8,9 PC tubules, which have been studied extensively by Schnur, Yager, and coworkers (80) (81) (82) , have been utilized for the templating of a wide variety of materials, and several biological/biomedical applications of controlled release from these tubules have been explored. For example, microtubules have been used as templates for the deposition of metal coatings, resulting in the formation of metal microcylinders (83, 84 ). The metal microcylinders were then filled with an antibiotic-containing resin and added to marine paint to impart anti-fouling properties to the hulls of ships (85) . This composite paint was found to be effective for releasing antibiotics for several months. One medical application of microtubules that has been explored is the use of DC 8, 9 PC tubules for the release of growth factors for nerve regeneration (86) . Many existing growth factor encapsulation methods utilize biodegradable polymers, which require the use of biomolecule-damaging organic solvents in their processing. Using phospholipid microcylinders, fragile biomolecules such as peptide growth factors can be encapsulated with mild solvent and temperature conditions. Growth factor-laden DC 8,9 PC tubules were able to release growth factors in physiologically relevant amounts for at least seven days in vitro (86) .
Recently, the minimum diameter of DC 8, 9 PC tubules has been reduced into the sub-100 nm range by the use of a 1:1 mixture of DC 8, 9 PC and 1,2-bis(dinonanoyl)-sn-glycero-3-phosphocholine (DNPC) (87) . The DC 8, 9 PC/DNPC mixture induces formation of lipid nanotubules with diameters in the 50 to 60 nm range ( Figure 11 ). These tubules are tens of microns in length and are also hollow, with three to four lipid bilayers making up each wall. Unfortunately, it is too early to say with any certainty how, or even if, these lipid nanotubules can be used as controlled release devices. One of the obstacles to their use as biomaterials may be their instability at body temperature. DC 8, 9 PC/DNPC nanotubules were found to undergo morphological changes when stored at or above ambient temperature (87) . However, it is interesting to note that this instability may actually give rise to another biomaterial application. Heating of DC 8, 9 PC/DNPC nanotubules from sub-ambient to body temperature gives rise to the formation of helical lipid ribbons, which interconnect in three dimensions to form a physical gel (Figure 12 ). These gels consist of greater than 98% water and could be exploited as biocompatible lipid scaffolds for tissue-engineering and drug-delivery applications. It is also conceivable that the thermally triggered nanotubule-helical ribbon transformation could be exploited to drive a fluid-gel transition of an injectable nanotubule suspension.
Lamellar hydrogels consisting of water-swollen mixtures of saturated phosphatidylcholines and PEGylated lipids (e.g., PEG-DMPE) have been recently developed (88, 89) . These gels consist of a network of connected fluid membranes containing phospholipids and small amounts of PEG-lipids that reside in regions of high membrane curvature. Such lipid-based hydrogels are expected to be biocompatible and potentially useful for drug delivery applications and could play host to bioactive membrane-embedded proteins.
Bicontinuous lipid emulsions have been exploited as templates to form threedimensional inorganic mineral scaffolds whose structure reflects that of the lipid assemblies that were used in their formation (90) (91) (92) (93) . In these systems, reactions between mineralizing species are confined to the interconnecting water channels of the bicontinuous network, leading to highly complex, interconnected mineral frameworks. Such approaches have significant future potential for constructing mineral, polymer, and composite scaffold structures for biomedical applications. Potential uses of such materials include the design of nanostructured materials for controlled drug delivery, as well as new scaffolds for tissue engineering.
Monolayers, Supported Bilayers, and Membrane-Mimetic Polymers: Biocompatible/Bioactive Surface Coatings
Phospholipids have also been extensively investigated as biomaterials in the form of phospholipid polymers and coatings that take advantage of the hemo-compatible and non-thrombogenetic properties of phospholipids. Several strategies have been developed that utilize either phospholipid monolayers/bilayers (94) or phosphorylcholine groups incorporated into designed polymers (95) . These approaches are inspired by the fact that 90% of the phospholipids of the outer membrane of red blood cells possess phosphorylcholine head groups, and it is the phosphorylcholine moiety that is important in promoting thromboresistance (96) .
A simple approach for generating such membrane-mimetic surfaces is to create supported lipid bilayers at the surface of bulk materials. These may be constructed in several ways, e.g., the Langmuir-Blodgett technique or fusion of a lipid monolayer onto a self-assembled alkylsilane-treated surface. The more robust systems have a covalent coupling of a phosphorylcholine head group to the substrate surface. Early efforts in this area utilized phospholipids as nonthrombogenic coatings on existing implant materials (97) (98) (99) (100) . Several efforts to coat biomaterials with lipids have used diacetylenic phospholipids in monomeric (97, 101) or polymeric (97, 102) form. In animal studies, these coatings performed as well as surfaces that had been coated with heparin (101) , showing the antithrombogenic potential for lipid-coated surfaces. Membrane-mimetic strategies are currently being employed in increasingly complex ways in an effort to more completely imitate the structure of natural biomembranes. The general goal of these studies is to engineer a bioactive surface by incorporating selected proteins/peptides into lipid membrane structures, either by formation of lipid films onto bulk materials or by the chemical conjugation of lipid precursors into a solid matrix. Dori and coworkers recently used the Langmuir-Blodgett technique to form hybrid peptide amphiphile/phospholipid monolayers on hydrophobic supports (103) . This approach was designed to yield a biologically active membrane-mimetic surface containing ligands of controlled accessibility to proteins and cells in solution. By controlling accessibility to surface bound ligands, the investigators were able to manipulate the extent of endothelial cell attachment and spreading on hybrid monolayer surfaces. These types of approaches involving functionalized lipid surfaces have significant biomedical potential in the design of medical devices and biosensors with highly controlled surface bioactivity.
Chaikof and coworkers have suggested that supported bilayers could be used to synthesize biomaterials and biosensors with a high degree of similarity to the natural surface of cells and have explored the parameters necessary for controlling the kinetics of multicomponent monolayer formation (104) . Furthermore, lipopeptide conjugates (105) are being explored for the modification of such self-assembling supported lipid bilayer surfaces with receptor-activating peptide sequences, and the stability of these supported bilayers has been improved with polymerization of lipid tails after bilayer formation (106) . Another possibility that has been explored is patterning individual domains of supported bilayers using microstamping techniques (107) . Using such a technique, cells contacting the patterned bilayer could be confined and controlled regio-selectively to study or induce responses that are spatially dependent.
Using the red blood cell membrane as a model, polymers that include phosphorylcholine side-chains have been developed as nonthrombogenic coatings for existing materials. One polymer that has been extensively studied is a copolymer of methacrylate and methacryloyloxyethyl phosphorylcholine (MPC), a monomer used to simulate the polar head groups of phospholipids (108, 109) . These copolymers exhibit low protein adsorption characteristics, which are thought to be the basis of their suppression of clot formation. One hypothesis suggested for the low protein adsorption of these materials is that it is a result of the phospholipid-like polymer having a high free-water fraction that disfavors protein conformational change at the surface (110) . Several materials have been investigated as substrates for coating with phosphorylcholine-containing polymers, including cellulose dialysis membranes (111) , polyurethane (112) , polysulfone (113) , and polyethylene (114) .
In addition to their anti-protein adsorption characteristics, phosphorylcholinecontaining polymers can preferentially adsorb natural phospholipids found in the fluid surrounding the implant. Natural synovial fluids contain phospholipids that act as a boundary lubricant, and elastomeric polymers with phosphorylcholine side chains have been investigated as articular surfaces to attract these naturally occurring phospholipids to the wear surface of the implant (115) . The authors propose to take advantage of spontaneous lipid adsorption from the synovial fluid to lubricate articular surfaces in total joint replacements.
SUMMARY
In this review we have discussed the structural and self-assembling characteristics of phospholipids, how lipid assemblies are utilized in nature, and current ways in which these biological strategies are being exploited to synthesize novel synthetic biomaterials. Several emerging approaches in biomaterials research take advantage of phospholipids to encapsulate and/or template via self-assembled structures such as liposomes and tubules, whereas others exploit the inherent biocompatibility of lipids for engineering novel tissue-contacting biomaterials that mimic biological membranes.
We have used several examples from the world of biomineralization to illustrate the compartmentalization and templating roles that phospholipids play during formation of biogenic materials with controlled micro-and nanostructures. Phospholipids, often in the form of bilayer vesicles, are commonly employed in biomineralization processes to delineate reaction compartments within which mineral formation takes place. The encapsulation ability of phospholipid vesicles can be exploited for biomaterial applications by entrapment of liposomes within polymer hydrogels for local site-directed delivery of therapeutic agents. A more sophisticated use of phospholipid vesicle compartmentalization involves the use of stimuli-responsive liposomes for rapid injectable in situ-forming biomaterials. In this approach, stimuli-responsive liposomes actively participate in the formation of mineral, polymer, and mineral/polymer composite biomaterials. The use of liposomes in this manner represents a departure from the traditional use of liposomes as delivery vehicles for topical or intravenous administration of entrapped drugs, genetic material, enzymes, and contrast agents. In the future, this versatile strategy could be utilized for minimally invasive administration of biomaterials for tissue repair, reconstructive surgery, and local site-directed drug delivery.
In addition to vesicles, several emerging applications of phospholipid assemblies and membrane-mimetic materials in the form of tubules, monolayers, and lipid gels have been reviewed. Lipid-based tubule structures have potential significance in drug-delivery applications owing to their unique release kinetics and are beginning to be investigated in this capacity. Recent progress on developing lipidbased hydrogels consisting of either fluid polymer-lipid bilayers or interconnected helical lipid ribbons may lead to new applications of lipids as hydrogel matrices for tissue-engineering or drug-delivery applications. Finally, bulk materials coated with lipid monolayers and bilayers offer the promise of biocompatibility, as well as the potential to be optimized for control of surface bioactivity. Many membranemimetic strategies employ either modified lipids or lipid-mimetic polymers. As methods for more precise control of surface chemistry are refined and the reproducibility and robustness of these structures improves, they will enable even more sophisticated uses of such structures as biomaterials.
